Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • boss_hoss
    replied
    I agree with genomeseeker - if the raw wells are low, this indicates a problem with the final enriched bead count going into the sequencing reaction.

    If your read length distribution is strange, consider changing your cpb going into emPCR. This may be an artifact of mixed signals.

    Both these problems could be linked - if an improper count was found after enrichment, enrichment % would be miscalculated.

    Leave a comment:


  • genomeseeker
    replied
    If your raw wells are lower than expected check these things:
    - equipment used for bead counting after enrichment; new settings required for Ti's smaller beads.
    - enrichment procedure; maybe you're carrying over a large amount null beads to your sequencing run.

    Leave a comment:


  • Drizzt
    replied
    Originally posted by SeqWhiskey View Post
    We just got the new emPCR kits with the mysterious "additive", so hopefully this helps. It is supposed to improve bead quality and we can now start using beads with up to 20% enrichment, much different than the previous 8% recommendation.... When I talk to our Roche tech I'll let you know if we find anything useful.

    Best, Matt
    The "additive" should increase your output and read length. It is interesting that some kits have had this problem and others haven't been affected within the same lot numbers. I have not used the additive but have heard good things from other labs. I would be interested in hearing your results.


    D

    Leave a comment:


  • SeqWhiskey
    replied
    We just got the new emPCR kits with the mysterious "additive", so hopefully this helps. It is supposed to improve bead quality and we can now start using beads with up to 20% enrichment, much different than the previous 8% recommendation.... When I talk to our Roche tech I'll let you know if we find anything useful.

    Best, Matt

    Leave a comment:


  • SeqWhiskey
    replied
    We're having the same problem. Raw wells are lower by an order of magnitude than what they should be, read length is much lower than it should be it just tapers off, very few quality reads. Our FLX runs have been excellent though and we just ran an FLX after the most recent Ti failure... We're contacting our rep, tech support and everyone else we can get ahold of but... so far Ti has not delivered. at all.

    Leave a comment:


  • Drizzt
    replied
    Have you just started experiencing these problems? Are you having problems enriching beads as well? What percentage of raw wells are you seeing? Example, how many beads are you loading and how many are registering as raw wells?
    I would talk with your Roche/454 rep and see if they have any information.



    Originally posted by pr0t3us View Post
    Hi to everybody,

    we have a 454-Titanium. We made some runs, but we have never obtained good results.
    With 454-GS-FLX, we have never had problems; major of runs was like expected. With Titanium we obtain poor runs (less reads than expected, strange read length distribution, less raw weels then expected) .

    Has someone the same problems ?

    Leave a comment:


  • pr0t3us
    started a topic Titanium Runs

    Titanium Runs

    Hi to everybody,

    we have a 454-Titanium. We made some runs, but we have never obtained good results.
    With 454-GS-FLX, we have never had problems; major of runs was like expected. With Titanium we obtain poor runs (less reads than expected, strange read length distribution, less raw weels then expected) .

    Has someone the same problems ?

Latest Articles

Collapse

  • seqadmin
    Understanding Genetic Influence on Infectious Disease
    by seqadmin




    During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

    Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
    Today, 10:59 AM
  • seqadmin
    Addressing Off-Target Effects in CRISPR Technologies
    by seqadmin






    The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
    08-27-2024, 04:44 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 09-06-2024, 08:02 AM
0 responses
13 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-03-2024, 08:30 AM
0 responses
18 views
0 likes
Last Post seqadmin  
Started by seqadmin, 08-27-2024, 04:40 AM
0 responses
25 views
0 likes
Last Post seqadmin  
Started by seqadmin, 08-22-2024, 05:00 AM
0 responses
387 views
0 likes
Last Post seqadmin  
Working...
X